Calidi Biotherapeutics, Inc. (CLDI)
NYSEAMERICAN: CLDI · Real-Time Price · USD
0.2805
-0.0145 (-4.92%)
Jun 20, 2025, 4:00 PM - Market closed
Calidi Biotherapeutics Market Cap
Calidi Biotherapeutics has a market cap or net worth of $9.42 million as of June 20, 2025. Its market cap has decreased by -15.89% in one year.
Market Cap
9.42M
Enterprise Value
3.57M
1-Year Change
-15.89%
Ranking
Category
Stock Price
$0.28
Market Cap Chart
Since November 1, 2021, Calidi Biotherapeutics's market cap has decreased from $273.84M to $9.42M, a decrease of -96.56%. That is a compound annual growth rate of -60.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 9.91M | -55.39% |
| Dec 31, 2024 | 22.21M | -58.52% |
| Dec 29, 2023 | 53.55M | -46.69% |
| Dec 30, 2022 | 100.46M | -64.38% |
| Dec 30, 2021 | 282.04M | 2.99% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 710.32B |
| Johnson & Johnson | 366.64B |
| Novo Nordisk | 334.60B |
| AbbVie | 327.63B |
| UnitedHealth Group | 280.19B |
| Abbott Laboratories | 230.15B |
| Novartis AG | 229.92B |
| AstraZeneca | 223.18B |